David Scadden, Director at AGIOS PHARMACEUTICALS INC (AGIO), bought 200 shares at $83.44 ($17K) on 2018-03-16, disclosed to the SEC on 2018-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AGIO | SELL | 2025-10-02 | $8K | — | Filing → |
| AGIO | SELL | 2025-08-29 | $8K | — | Filing → |
| AGIO | SELL | 2025-07-15 | $56K | — | Filing → |